On the evening of October 31 I wrote that a decision onwhat to do with the Netkar Therapeutics options (NKTR180119C00022000)--the January 19, 2018 call at $22--that I added to my Volatility Portfolio back on May 16, 2017 at a price of $2.64 (the closing options price on that day) was a hard one. As of that […]
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the site. And we'll throw in the first week free! If you change your mind during that first week, just cancel your subscription from your profile page, and you won't be billed anything.
